Your browser doesn't support javascript.
loading
JNTX-101, a novel albumin-encapsulated gemcitabine prodrug, is efficacious and operates via caveolin-1-mediated endocytosis.
Cui, Tiantian; Corrales-Guerrero, Sergio; Castro-Aceituno, Veronica; Nair, Sindhu; Maneval, Daniel C; Monnig, Curtis; Kearney, Patrick; Ellis, Sam; Raheja, Nicholas; Raheja, Neil; Williams, Terence M.
Afiliación
  • Cui T; Department of Radiation Oncology, City of Hope National Medical Center, Duarte, CA 91010, USA.
  • Corrales-Guerrero S; Biomedical Sciences Graduate Program, The Ohio State University, Columbus, OH 43210, USA.
  • Castro-Aceituno V; Department of Radiation Oncology, City of Hope National Medical Center, Duarte, CA 91010, USA.
  • Nair S; Department of Radiation Oncology, City of Hope National Medical Center, Duarte, CA 91010, USA.
  • Maneval DC; January Therapeutics, San Diego, CA 92121, USA.
  • Monnig C; January Therapeutics, San Diego, CA 92121, USA.
  • Kearney P; January Therapeutics, San Diego, CA 92121, USA.
  • Ellis S; January Therapeutics, San Diego, CA 92121, USA.
  • Raheja N; January Therapeutics, San Diego, CA 92121, USA.
  • Raheja N; January Therapeutics, San Diego, CA 92121, USA.
  • Williams TM; Department of Radiation Oncology, City of Hope National Medical Center, Duarte, CA 91010, USA.
Mol Ther Oncolytics ; 30: 181-192, 2023 Sep 21.
Article en En | MEDLINE | ID: mdl-37674628

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Mol Ther Oncolytics Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Mol Ther Oncolytics Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos